Understanding how a flexible cell type affects lung cancer

Determining the role and function of a high plasticity cell state in lung adenocarcinoma

NIH-funded research Sloan-Kettering Inst Can Research · NIH-10888274

This study is looking at how certain flexible cells in lung adenocarcinoma, a type of lung cancer, help the tumors grow and resist treatments, with the hope of finding ways to improve outcomes for patients.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10888274 on NIH RePORTER

What this research studies

This research investigates the role of a specific high plasticity cell state in lung adenocarcinoma, a common and aggressive form of lung cancer. By analyzing single cell transcriptomes from mouse models and human tumors, the researchers aim to understand how this cell state contributes to tumor growth and resistance to treatments. The study involves profiling these cells at various stages of cancer progression and examining their behavior under therapeutic stress. The goal is to uncover the mechanisms behind tumor plasticity and its impact on patient outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with lung adenocarcinoma, particularly those experiencing treatment resistance.

Not a fit: Patients with other types of lung cancer or those who are not currently undergoing treatment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for overcoming treatment resistance in lung cancer patients.

How similar studies have performed: Previous research has shown that targeting tumor plasticity can improve treatment outcomes, suggesting that this approach may hold promise.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Advanced CancerAnti-Cancer Agents
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.